Jiehui Tan

495 total citations
16 papers, 210 citations indexed

About

Jiehui Tan is a scholar working on Surgery, Oncology and Cell Biology. According to data from OpenAlex, Jiehui Tan has authored 16 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Jiehui Tan's work include Pancreatitis Pathology and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Jiehui Tan is often cited by papers focused on Pancreatitis Pathology and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Jiehui Tan collaborates with scholars based in China, United Kingdom and United States. Jiehui Tan's co-authors include Guowei Zhang, Lei Zhou, Xuemei Chen, Yujie Yuan, Zhitao Chen, Min Tan, Weijun Dai, Jia Xu, Zhitao Zhou and Min Luo and has published in prestigious journals such as Cell Death and Disease, Theranostics and Digestive Diseases and Sciences.

In The Last Decade

Jiehui Tan

16 papers receiving 204 citations

Peers

Jiehui Tan
Masashi Kurobe Japan
Angelique Levert‐Mignon Australia
Rebecca McCann United Kingdom
Justin H. Gundelach United States
Yining Wang China
Min Rong United States
Irene Zouboulis-Vafiadis Greece
Fuminori Ito Japan
Fumiyuki Sato Japan
Ann D Fisher United Kingdom
Masashi Kurobe Japan
Jiehui Tan
Citations per year, relative to Jiehui Tan Jiehui Tan (= 1×) peers Masashi Kurobe

Countries citing papers authored by Jiehui Tan

Since Specialization
Citations

This map shows the geographic impact of Jiehui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiehui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiehui Tan more than expected).

Fields of papers citing papers by Jiehui Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiehui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiehui Tan. The network helps show where Jiehui Tan may publish in the future.

Co-authorship network of co-authors of Jiehui Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiehui Tan. A scholar is included among the top collaborators of Jiehui Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiehui Tan. Jiehui Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tan, Jiehui, Man Shu, Junbin Liao, et al.. (2023). Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(13). 12365–12377. 7 indexed citations
2.
Wang, Xiao, Wan-jun Yang, Jiehui Tan, et al.. (2022). Roles and Clinical Significances of ATF6, EMC6, and APAF1 in Prognosis of Pancreatic Cancer. Frontiers in Genetics. 12. 730847–730847. 16 indexed citations
3.
Chen, Zebin, Shunli Shen, Wenxuan Xie, et al.. (2022). Comparison of clinical efficacy between LAPS and ALPPS in the treatment of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology report. 11. goad060–goad060. 3 indexed citations
4.
Xie, Wenxuan, Jiehui Tan, Бин Ли, et al.. (2021). Comparison of Hepatic Resection with Percutaneous Ablation for Hepatocellular Carcinoma in the Caudate Lobe Within Milan Criteria. Journal of Gastrointestinal Surgery. 26(2). 323–332. 1 indexed citations
5.
Tan, Jiehui, Lei Zhou, Zhitao Zhou, et al.. (2020). ATF6 aggravates acinar cell apoptosis and injury by regulating p53/AIFM2 transcription in Severe Acute Pancreatitis. Theranostics. 10(18). 8298–8314. 60 indexed citations
6.
Tan, Jiehui, Lei Zhou, Zhitao Zhou, et al.. (2020). EMC6 regulates acinar apoptosis via APAF1 in acute and chronic pancreatitis. Cell Death and Disease. 11(11). 966–966. 19 indexed citations
7.
Tan, Jiehui, et al.. (2020). Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis. The Turkish Journal of Gastroenterology. 31(3). 246–256. 13 indexed citations
8.
Zhou, Lei, Jiehui Tan, Wanyan Zhou, et al.. (2020). P53 Activated by ER Stress Aggravates Caerulein-Induced Acute Pancreatitis Progression by Inducing Acinar Cell Apoptosis. Digestive Diseases and Sciences. 65(11). 3211–3222. 10 indexed citations
9.
Tan, Jiehui, Lei Zhou, Heping Kan, & Guowei Zhang. (2019). Parecoxib Improves the Outcomes of Acute Mild and Moderate Pancreatitis. Pancreas. 48(9). 1148–1154. 4 indexed citations
10.
Tan, Jiehui, Lei Zhou, & Guowei Zhang. (2019). Surgical Techniques for the Laparoscopic Treatment of Bile Duct Stones in Patients With a History of Upper Abdominal Operations: Retrospective Cohort Study. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 29(6). 503–508. 1 indexed citations
11.
Zhou, Lei, Jiehui Tan, Jia Xu, et al.. (2019). ATF6 regulates the development of chronic pancreatitis by inducing p53-mediated apoptosis. Cell Death and Disease. 10(9). 662–662. 19 indexed citations
12.
Tan, Jiehui, et al.. (2019). Risk factors for the concomitant occurrence of alcoholic chronic pancreatitis and alcoholic liver cirrhosis: a 10-years cohort study at a tertiary hospital in China. European Journal of Gastroenterology & Hepatology. 32(9). 1229–1234. 3 indexed citations
13.
14.
15.
16.
Tan, Jiehui, et al.. (2015). PWE-049 Vaccination of inflammatory bowel disease patients on immunomodulators and biologics. A233.1–A233. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Kurobe Breakdown of academic impact, for papers by Angelique Levert‐Mignon Breakdown of academic impact, for papers by Rebecca McCann Breakdown of academic impact, for papers by Justin H. Gundelach Breakdown of academic impact, for papers by Yining Wang Breakdown of academic impact, for papers by Min Rong Breakdown of academic impact, for papers by Irene Zouboulis-Vafiadis Breakdown of academic impact, for papers by Fuminori Ito Breakdown of academic impact, for papers by Fumiyuki Sato Breakdown of academic impact, for papers by Ann D Fisher
Rankless by CCL
2026